FDA approves AZT for pediatric AIDS patients under 13.
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D000740:Anemia / Q000139:chemically induced; D002648:Child; D002675:Child, Preschool; D006801:Humans; D007223:Infant; D015215:Zidovudine / Q000009:adverse effects / Q000627:therapeutic use*
D015215:Zidovudine